NCT05063331 - Patient-Centered Outcomes in the Surgical Treatment of Uterovaginal Prolapse | Biotech Hunter

Enrollment

320

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

July 31, 2030

Study Completion Date

July 31, 2030

Conditions

Uterine Prolapse

Interventions

PROCEDURE

Minimally invasive supracervical hysterectomy and sacrocolpopexy (MI-SCH+SCP)

Minimally invasive robotic or laparoscopic supracervical hysterectomy will be done, and the vaginal apex (including cervix) will be suspended utilizing sacrocolpopexy mesh to the anterior spinous ligament.

PROCEDURE

Vaginal hysterectomy with uterosacral ligament suspension (TVH+USLS)

The uterus will be removed vaginally and the vaginal apex will be suspended utilizing sutures in the uterosacral ligament.

Trial Locations (7)

15213

RECRUITING

University of Pittsburgh, UPMC Magee-Womens Hospital, Pittsburgh

27707

RECRUITING

Duke University, Durham

32224

RECRUITING

Mayo Clinic, Jacksonville

44106

RECRUITING

University Hospitals Cleveland Medical Center, Cleveland

44109

RECRUITING

MetroHealth Medical Center, Cleveland

44195

RECRUITING

Cleveland Clinic, Cleveland

60611

RECRUITING

Northwestern Medicine, Chicago